Blog

Emmanuel Thomas, MD, PhD of University of Miami School of Medicine to lead national board of directors.

A two-day virtual event on March 15th and 16th will bring together key stakeholders with one goal in mind—find solutions to improve health outcomes for all those suffering from rare autoimmune liver diseases.

We applaud President Biden's budget proposal to expand hepatitis C screening, testing, treatment, prevention, and monitoring. We urge the Administration to take similar action for NAFLD. 

Jontanna lived the typical life of an American high school student until she was diagnosed with a rare autoimmune liver disease. People like Jontanna need your help, please donate today! Give once or monthly.

Meet Mya Longacre, an ALF patient volunteer who has been navigating her journey with liver disease since birth.

We’re proud to launch our new Pediatric Liver Disease Information Center. Find disease specific information, patient stories, videos, activities, educational resources and more! Access the online site as a parent, teen or child to view age-appropriate information.

Like many newborns, Carter was born slightly jaundice. A few weeks after leaving the hospital, Carter began to develop bilateral inguinal hernias – something that would soon be a blessing in disguise.

February is Black History Month. Meet Dr. Rotonya Carr, MD, FACP - Cyrus E. Rubin Chair and Division Head of Gastroenterology at the University of Washington.

Caregivers serve as lifelines and are the primary source of love, support and strength for those in their care. In the U.S., many caregivers work jobs outside of the home in addition to providing full-time care.

The American Liver Foundation (ALF) is pleased to announce the winner of its 2022 Distinguished Scientific Achievement Award, David E. Cohen, MD, PhD of Brigham and Women’s Hospital, Boston, MA.

The American Liver Foundation (ALF) is proud to once again be a member of the TCS New York City Marathon Official Charity Program for the 2022 race, which takes place on Sunday, November 6, 2022, in New York City’s five boroughs.

This one-day virtual program brings together hundreds of leading biomedical scientists and physicians from across the globe and is designed to bridge the remarkable advances in basic biology and engineering with the understanding of liver diseases and their treatment.